MAT Tools and Resources

This issue brief discusses challenges and barriers to care faced by individuals in the LGBTQ+ community. It highlights challenges to receiving health insurance and accessing care and discusses health outcomes and policy opportunities.

This guide helps people seeking care navigate the behavioral healthcare system. It provides information on health insurance, where to seek treatment, how to find a provider and make an appointment, and how to make other choices in a patient's healthcare journey.

This training guides practitioners in treating LGBTQI+ patients. Its sections define this population and discuss how practitioners can improve health outcomes through best practices.

This issue brief and accompanying federal alignment tool offer a template for systematically evaluating how state activities align with each of the federal government's primary care intiatives. It also describes six key activities that will help states best leverage their authority.

These slides focus on substance use and mental health measures for several sub-populations in the United States, including American Indian and Alaska Native; Asian; Black or African; Female; Hispanic or Latino; Lesbian, Gay, or Bisexual Adult; Multiracial; Native Hawaiian and Other Pacific Islander; and Veteran populations.

This report, based on findings from the 2021 and 2022 National Surveys on Drug Use and Health (NSDUH) presents key substance use, mental health, and treatment indicators among adults aged 60 or older in the United States.

This dashboard presents data from the CDC's State Unintentional Drug Overdose Reporting System (SUDORS), which collects data on unintentional and undetermined intent drug overdose deaths.

This web page highlights statistics on deaths involving drugs commonly associated with fatal overdose from 1999-2022 collected by the National Center for Health Statistics (NCHS) at the Centers for Disease Control and Prevention.

These FAQs provide clarification regarding federal policy on coverage of peer support services.

This article surveyed laws and regulations in all 50 states and the District of Columbia, as well as criminal and civil judicial decisions in which opioid treatment agreements were discussed as evidence, finding minimal evidence that they effectively reduce opioid misuse or improve patient outcomes.